脂肪来源干细胞外泌体 circVMA21 通过靶向 miR-16-5P 减轻脓毒症诱导的急性肾损伤
该研究先鉴定脂肪来源干细胞及其外泌体,再用 LPS 诱导 HK-2 细胞损伤与小鼠 AKI 模型,观察 ADSCs-Exo 的作用及 circVMA21/miR-16-5p 轴。结果显示 ADSCs-Exo 抑制 LPS 诱导的 HK-2 细胞凋亡、炎症和有氧糖酵解;敲低外泌体 circVMA21 加重细胞损伤,miR-16-5p 抑制剂可逆转该加重效应。机制上 circVMA21 作为 miR-16-5p 的吸附海绵。动物实验中 ADSCs-Exo 通过升高 circVMA21、降低 miR-16-5p 保护 LPS 诱导的 AKI 小鼠。作者认为该轴为脓毒症相关 AKI 提供了潜在分子靶点。
要点
- ADSCs-Exo 可抑制 LPS 诱导的 HK-2 细胞凋亡、炎症和有氧糖酵解。
- 敲低 ADSCs 来源外泌体中的 circVMA21 会加重 LPS 诱导的 HK-2 细胞损伤。
- 双荧光素酶报告实验和 RIP 实验显示 circVMA21 可作为 miR-16-5p 的吸附海绵。
- miR-16-5p 抑制剂可逆转 Exo-sh-circVMA21 对 LPS 诱导细胞损伤的促进作用。
- 小鼠实验中 ADSCs-Exo 通过升高 circVMA21、降低 miR-16-5p 保护 LPS 诱导的 AKI。
适用人群与场景
- LPS 诱导的 HK-2 肾小管上皮细胞损伤模型
- LPS 诱导的急性肾损伤小鼠模型
研究设计与关键结果
- 研究类型为细胞与动物实验:脂肪来源干细胞经茜素红染色、油红 O 染色和流式细胞术鉴定,外泌体经透射电镜、纳米颗粒追踪分析、蛋白质印迹和免疫荧光鉴定。
- ADSCs-Exo 抑制 LPS 诱导的 HK-2 细胞凋亡(流式细胞术检测)、炎症细胞因子水平(ELISA 检测)和有氧糖酵解(乳酸检测试剂盒及有氧糖酵解相关标志物 qRT-PCR 检测)。
- 敲低 ADSCs 来源外泌体中的 circVMA21 增强 LPS 诱导的 HK-2 细胞损伤。
- 双荧光素酶报告实验和 RIP 实验显示 circVMA21 可作为 miR-16-5p 的吸附海绵。
- miR-16-5p 抑制剂逆转 Exo-sh-circVMA21 对 LPS 诱导细胞损伤的促进作用。
- 小鼠实验中 ADSCs-Exo 通过增加 circVMA21 表达、降低 miR-16-5p 表达保护 LPS 诱导的 AKI。
证据类型、等级与局限
- 证据类型:细胞实验与动物实验(LPS 诱导 HK-2 细胞模型及 LPS 诱导 AKI 小鼠模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为外泌体 circVMA21 通过靶向 miR-16-5p 缓解 LPS 诱导的 AKI,为脓毒症相关 AKI 提供了潜在分子靶点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Exosome from adipose-derived stem cells (ADSCs-Exo) has been shown to inhibit the progression of human diseases, including sepsis-related acute kidney injury (AKI). CircVMA21 is considered to be an important regulator for sepsis-related AKI. However, whether ADSCs-Exo affected sepsis-induced AKI by delivering circVMA21 is not clear. Methods: Adipose-derived stem cells were identified by alizarin red staining, oil red O staining, and flow cytometry. Exosome from adipose-derived stem cells was authenticated by transmission electron microscopy, nanoparticle tracking analysis, western blot analysis, and immunofluorescence assay. Cell apoptosis was assessed by flow cytometry, and inflammation cytokine levels were determined by ELISA. Lactate production was assessed using Lactate Acid Content Assay Kit. The expression levels of aerobic glycolysis-related markers, circVMA21 and miR-16-5p, was evaluated by quantitative real time-polymerase chain reaction. Dual-luciferase reporter assay and RIP assay were employed to detect RNA interaction. Animal experiments were used to evaluate the role of ADSCs-Exo on renal function and cell injury in LPS-induced AKI mice model. Results: Exosome from adipose-derived stem cells inhibited LPS-induced HK-2 cell apoptosis, inflammation, and aerobic glycolysis. Knockdown of exosomal circVMA21 derived from ADSCs enhanced HK-2 cell injury induced by LPS. In terms of mechanism, circVMA21 could serve as sponge for miR-16-5p. Besides, miR-16-5p inhibitor reversed the promotion effect of Exo-sh-circVMA21 on LPS-induced cell injury. In addition, ADSCs-Exo protected LPS-induced AKI in mice by increasing circVMA21 expression and decreasing miR-16-5p expression. Conclusion: Exosomal circVMA21 derived by ADSCs relieved LPS-induced AKI through targeting miR-16-5p, which provided a potential molecular target for treating sepsis-related AKI.
参考来源
- He Y, Li X, Huang B, et al. EXOSOMAL CIRCVMA21 DERIVED FROM ADIPOSE-DERIVED STEM CELLS ALLEVIATES SEPSIS-INDUCED ACUTE KIDNEY INJURY BY TARGETING MIR-16-5P. Shock. 2023. PMID: 37493568. doi:10.1097/SHK.0000000000002179
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。